These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 34257415)

  • 1. Pharmacological and genetic manipulations at the µ-opioid receptor reveal arrestin-3 engagement limits analgesic tolerance and does not exacerbate respiratory depression in mice.
    He L; Gooding SW; Lewis E; Felth LC; Gaur A; Whistler JL
    Neuropsychopharmacology; 2021 Dec; 46(13):2241-2249. PubMed ID: 34257415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of β-arrestin-2 in short- and long-term opioid tolerance in the dorsal root ganglia.
    Muchhala KH; Jacob JC; Dewey WL; Akbarali HI
    Eur J Pharmacol; 2021 May; 899():174007. PubMed ID: 33705801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness for the combination of G-protein- and β-arrestin-biased ligands of μ-opioid receptors: Prevention of antinociceptive tolerance.
    Mori T; Kuzumaki N; Arima T; Narita M; Tateishi R; Kondo T; Hamada Y; Kuwata H; Kawata M; Yamazaki M; Sugita K; Matsuzawa A; Baba K; Yamauchi T; Higashiyama K; Nonaka M; Miyano K; Uezono Y; Narita M
    Mol Pain; 2017; 13():1744806917740030. PubMed ID: 29056067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An opioid agonist that does not induce mu-opioid receptor--arrestin interactions or receptor internalization.
    Groer CE; Tidgewell K; Moyer RA; Harding WW; Rothman RB; Prisinzano TE; Bohn LM
    Mol Pharmacol; 2007 Feb; 71(2):549-57. PubMed ID: 17090705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine-induced respiratory depression is independent of β-arrestin2 signalling.
    Kliewer A; Gillis A; Hill R; Schmiedel F; Bailey C; Kelly E; Henderson G; Christie MJ; Schulz S
    Br J Pharmacol; 2020 Jul; 177(13):2923-2931. PubMed ID: 32052419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ß-arrestin 2 germline knockout does not attenuate opioid respiratory depression.
    Bachmutsky I; Wei XP; Durand A; Yackle K
    Elife; 2021 May; 10():. PubMed ID: 34002697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biased Opioid Ligands.
    Faouzi A; Varga BR; Majumdar S
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32948048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex formation between the vasopressin 1b receptor, β-arrestin-2, and the μ-opioid receptor underlies morphine tolerance.
    Koshimizu TA; Honda K; Nagaoka-Uozumi S; Ichimura A; Kimura I; Nakaya M; Sakai N; Shibata K; Ushijima K; Fujimura A; Hirasawa A; Kurose H; Tsujimoto G; Tanoue A; Takano Y
    Nat Neurosci; 2018 Jun; 21(6):820-833. PubMed ID: 29713080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2.
    Váradi A; Marrone GF; Palmer TC; Narayan A; Szabó MR; Le Rouzic V; Grinnell SG; Subrath JJ; Warner E; Kalra S; Hunkele A; Pagirsky J; Eans SO; Medina JM; Xu J; Pan YX; Borics A; Pasternak GW; McLaughlin JP; Majumdar S
    J Med Chem; 2016 Sep; 59(18):8381-97. PubMed ID: 27556704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence.
    Bohn LM; Gainetdinov RR; Lin FT; Lefkowitz RJ; Caron MG
    Nature; 2000 Dec; 408(6813):720-3. PubMed ID: 11130073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biased versus Partial Agonism in the Search for Safer Opioid Analgesics.
    Azevedo Neto J; Costanzini A; De Giorgio R; Lambert DG; Ruzza C; Calò G
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32854452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo activity of cyclopeptide Dmt-c[d-Lys-Phe-Asp]NH
    Gach-Janczak K; Piekielna-Ciesielska J; Adamska-Bartłomiejczyk A; Wtorek K; Ferrari F; Calo' G; Szymaszkiewicz A; Piasecka-Zelga J; Janecka A
    Peptides; 2018 Jul; 105():51-57. PubMed ID: 29684591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Opioid Analgesics for the Development of Transdermal Opioid Patches That Possess Morphine-Like Pharmacological Profiles Rather Than Fentanyl: Possible Opioid Switching Alternatives Among Patch Formula.
    Komatsu A; Miyano K; Nakayama D; Mizobuchi Y; Uezono E; Ohshima K; Karasawa Y; Kuroda Y; Nonaka M; Yamaguchi K; Iseki M; Uezono Y; Hayashida M
    Anesth Analg; 2022 May; 134(5):1082-1093. PubMed ID: 35427270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The μ-opioid receptor-mediated G
    Xia J; Li X; Zhu H; Zhou X; Chen J; Li Q; Li S; Chu H; Dong M
    Eur J Pharmacol; 2024 Mar; 966():176333. PubMed ID: 38278466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation-deficient G-protein-biased μ-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects.
    Kliewer A; Schmiedel F; Sianati S; Bailey A; Bateman JT; Levitt ES; Williams JT; Christie MJ; Schulz S
    Nat Commun; 2019 Jan; 10(1):367. PubMed ID: 30664663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of G protein bias and β-arrestin 2 signaling in opioid-induced respiratory depression.
    Bateman JT; Levitt ES
    Am J Physiol Cell Physiol; 2021 Oct; 321(4):C681-C683. PubMed ID: 34469203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new potent analgesic agent with reduced liability to produce morphine tolerance.
    Kiraly K; Caputi FF; Hanuska A; Kató E; Balogh M; Köles L; Palmisano M; Riba P; Hosztafi S; Romualdi P; Candeletti S; Ferdinandy P; Fürst S; Al-Khrasani M
    Brain Res Bull; 2015 Aug; 117():32-8. PubMed ID: 26235542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonist dependency of the second phase access of β-arrestin 2 to the heteromeric µ-V1b receptor.
    Ngamlertwong N; Tsuchiya H; Mochimaru Y; Azuma M; Kuchimaru T; Koshimizu TA
    Sci Rep; 2021 Aug; 11(1):15813. PubMed ID: 34349143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-Arrestin-2 knockout prevents development of cellular μ-opioid receptor tolerance but does not affect opioid-withdrawal-related adaptations in single PAG neurons.
    Connor M; Bagley EE; Chieng BC; Christie MJ
    Br J Pharmacol; 2015 Jan; 172(2):492-500. PubMed ID: 24597632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of arrestin-3 does not reduce drug-seeking behavior in a longitudinal paradigm of oral morphine self-administration.
    Gooding SW; Felth L; Foxall R; Rosa Z; Ireton K; Sall I; Gipoor J; Gaur A; King M; Dirks N; Whistler CA; Whistler JL
    Front Pharmacol; 2024; 15():1438037. PubMed ID: 39391692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.